EUCTR2009-018034-11-SE进行中（未招募）不适用
Open pilot study of treatment with vancomycin to children and adolescents with primary sclerosing cholangitis - vanco-psc
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Children and adolescents > 1 year < 20 years who have MRC verified PSC and markers of disease which can easily be followed until normalisation:
- •- jaundice, itching and ascites
- •- increased liver function tests
- •- The initial liver biopsy consistent with PSC, not compulsory.
- •- Colonoscopy
- •The patients should be newly diagnosed or therapy resistant to commonly used therapy.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 20
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known hypersensitivity towards vancomycin
- •Chronic renal failure.
研究者
相似试验
已完成
不适用
Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult PopulationVancomycinAdultArea Under CurveNCT04756895CR-CSSS Champlain-Charles-Le Moyne45
招募中
不适用
Assessment of the risks and benefits of Vancomycin use in patients with infectioCritical patients, sepsis, acute kidney injury, dialysis, vancomycinC12.777.419.780.050D09.400.420.925C01.539.757E05.196.353RBR-4zrwtzDepartamento de Clínica Médica da Faculdade de Medicina de Botucatu
招募中
不适用
Development of a new dosing strategy of vancomycin using target concentration-controlled infusioKCT0003462Asan Medical Center386
已完成
不适用
Evaluation of a new vancomycin dosage guideline in pediatric oncology patients.Antibioticum therapie10004018NL-OMON40472Academisch Medisch Centrum50
终止
4 期
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)Clostridium Difficile InfectionClostridium Difficile Infection RecurrenceNCT04000555University of South Florida26